Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140491 · ClinicalTrials.gov registry record · NA
Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00140491 is a NA study that has completed, run by Emory University. The registered enrollment target is 20 participants.
The verdict
NCT00140491, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this pilot study is to evaluate the effect of Vision Restoration Therapy, VRT, on the visual function of patients with unilateral or bilateral AION, who have good central vision (at least 20/60) and altitudinal visual field defects.
Interventions
- DEVICE Vision Restoration Therapy (NOVAVISION)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00140491
The ClinicalTrials.gov registry entry for NCT00140491 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vision Restoration Therapy (NOVAVISION) is the first listed.
NCT00140491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00140491 about?
NCT00140491 is a clinical study titled "Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy". The goal of this pilot study is to evaluate the effect of Vision Restoration Therapy, VRT, on the visual function of patients with unilateral or bilateral AION, who have good central vision (at least 20/60) and altitudinal visual field defects.
What is the current status of trial NCT00140491?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2005-08. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00140491?
The interventions under investigation include: Vision Restoration Therapy (NOVAVISION) (DEVICE).
Who is sponsoring clinical trial NCT00140491?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.